Willy A. Solis

2.5k total citations · 1 hit paper
14 papers, 1.1k citations indexed

About

Willy A. Solis is a scholar working on Oncology, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Willy A. Solis has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Willy A. Solis's work include HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). Willy A. Solis is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). Willy A. Solis collaborates with scholars based in United States and Canada. Willy A. Solis's co-authors include Daniel W. Nebert, Timothy P. Dalton, Matthew Z. Dieter, Amy L. Roe, Yi Yang, Michael J. Carvan, Lei He, Judy M. Harrer, Howard G. Shertzer and Lashitew Gedamu and has published in prestigious journals such as Cancer Research, Environmental Health Perspectives and Archives of Biochemistry and Biophysics.

In The Last Decade

Willy A. Solis

13 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis

2000 813 citations Daniel W. Nebert, Amy L. Roe et al. Biochemical Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Willy A. Solis United States	10	500	437	281	139	118	14	1.1k
Brett D. Hollingshead United States	11	419 0.8×	519 1.2×	247 0.9×	124 0.9×	119 1.0×	20	1.2k
Simon Ducheix France	19	300 0.6×	429 1.0×	193 0.7×	52 0.4×	82 0.7×	26	1.1k
Danica E. DeGroot United States	8	444 0.9×	285 0.7×	214 0.8×	83 0.6×	65 0.6×	9	947
David L. Busbee United States	20	300 0.6×	582 1.3×	422 1.5×	193 1.4×	167 1.4×	80	1.5k
Giocondo Lorenzon France	13	236 0.5×	373 0.9×	285 1.0×	70 0.5×	139 1.2×	23	980
Nadine Dragin France	22	324 0.6×	394 0.9×	263 0.9×	280 2.0×	216 1.8×	32	1.6k
Michael Schwarz Germany	16	385 0.8×	365 0.8×	301 1.1×	74 0.5×	106 0.9×	23	928
G. Jean Horbach Netherlands	20	182 0.4×	380 0.9×	247 0.9×	234 1.7×	184 1.6×	45	1.0k
R. Bars France	25	386 0.8×	550 1.3×	249 0.9×	432 3.1×	269 2.3×	51	1.7k
Dexter Morin United States	23	183 0.4×	841 1.9×	309 1.1×	187 1.3×	71 0.6×	53	1.5k

Countries citing papers authored by Willy A. Solis

Since Specialization

Citations

This map shows the geographic impact of Willy A. Solis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willy A. Solis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willy A. Solis more than expected).

Fields of papers citing papers by Willy A. Solis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willy A. Solis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willy A. Solis. The network helps show where Willy A. Solis may publish in the future.

Co-authorship network of co-authors of Willy A. Solis

This figure shows the co-authorship network connecting the top 25 collaborators of Willy A. Solis. A scholar is included among the top collaborators of Willy A. Solis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willy A. Solis. Willy A. Solis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Mendelsohn, Brian A., Kathleen R. Gogas, Jeffrey N. Higaki, et al.. (2025). Preclinical Characterization of XB010: A Novel Antibody–Drug Conjugate for the Treatment of Solid Tumors that Targets Tumor-Associated Antigen 5T4. Molecular Cancer Therapeutics. 24(12). 1856–1866. 1 indexed citations

Ahn, Shin Hye, Brett A. Vaughn, Willy A. Solis, et al.. (2020). Site-Specific ⁸⁹Zr- and ¹¹¹In-Radiolabeling and In Vivo Evaluation of Glycan-free Antibodies by Azide–Alkyne Cycloaddition with a Non-natural Amino Acid. Bioconjugate Chemistry. 31(4). 1177–1187. 17 indexed citations

Abrahams, Cristina L., Willy A. Solis, Toni Kline, et al.. (2018). Preclinical activity and safety of STRO-002, a novel ADC targeting folate receptor alpha for ovarian cancer. Gynecologic Oncology. 149. 50–50. 1 indexed citations

Abrahams, Cristina L., Xiaofan Li, Millicent Embry, et al.. (2018). Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001. Oncotarget. 9(102). 37700–37714. 45 indexed citations

Gupta, Nidhi, Willy A. Solis, Reina N. Fuji, et al.. (2014). Abstract 4502: Nonclinical characterization and tolerability of a surrogate anti-mesothelin-MMAE antibody-drug conjugate. Cancer Research. 74(19_Supplement). 4502–4502. 1 indexed citations

Lin, Kedan, Crystal Zhang, Eric B. Harstad, et al.. (2013). Abstract 5619: Preclinical development of anti-SLC34A2 antibody drug conjugate as a therapeutic for non-small cell lung and ovarian cancers.. Cancer Research. 73(8_Supplement). 5619–5619.

Nebert, Daniel W., Gary W. Stuart, Willy A. Solis, & Michael J. Carvan. (2002). Use of Reporter Genes and Vertebrate DNA Motifs in Transgenic Zebrafish as Sentinels for Assessing Aquatic Pollution. Environmental Health Perspectives. 110(1). a15–a15. 12 indexed citations

Solis, Willy A., et al.. (2002). Retrovirally Expressed Metal Response Element-Binding Transcription Factor-1 Normalizes Metallothionein-1 Gene Expression and Protects Cells against Zinc, but Not Cadmium, Toxicity. Toxicology and Applied Pharmacology. 178(2). 93–101. 13 indexed citations

Solis, Willy A., Timothy P. Dalton, Matthew Z. Dieter, et al.. (2002). Glutamate–cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress. Biochemical Pharmacology. 63(9). 1739–1754. 101 indexed citations

10.

Dieter, Matthew Z., et al.. (2001). Tryphostin AG879, a tyrosine kinase inhibitor: prevention of transcriptional activation of the electrophile and the aromatic hydrocarbon response elements. Biochemical Pharmacology. 61(2). 215–225. 20 indexed citations

11.

Carvan, Michael J., Willy A. Solis, Lashitew Gedamu, & Daniel W. Nebert. (2000). Activation of Transcription Factors in Zebrafish Cell Cultures by Environmental Pollutants. Archives of Biochemistry and Biophysics. 376(2). 320–327. 34 indexed citations

12.

Dalton, Timothy P., Willy A. Solis, Daniel W. Nebert, & Michael J. Carvan. (2000). Characterization of the MTF-1 transcription factor from zebrafish and trout cells. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 126(3). 325–335. 45 indexed citations

13.

Nebert, Daniel W., Amy L. Roe, Matthew Z. Dieter, et al.. (2000). Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochemical Pharmacology. 59(1). 65–85. 813 indexed citations breakdown →

14.

Carvan, Michael J., et al.. (1999). Trout CYP1A3 Gene: Recognition of Fish DNA Motifs by Mouse Regulatory Proteins. Marine Biotechnology. 1(2). 155–166. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact